Your browser doesn't support javascript.
Household Transmission and Symptomology of Severe Acute Respiratory Syndrome Coronavirus 2 Alpha Variant among Children-California and Colorado, 2021.
Waltenburg, Michelle A; Whaley, Melissa J; Chancey, Rebecca J; Donnelly, Marisa A P; Chuey, Meagan R; Soto, Raymond; Schwartz, Noah G; Chu, Victoria T; Sleweon, Sadia; McCormick, David W; Uehara, Anna; Retchless, Adam C; Tong, Suxiang; Folster, Jennifer M; Petway, Marla; Thornburg, Natalie J; Drobeniuc, Jan; Austin, Brett; Hudziec, Meghan M; Stringer, Ginger; Albanese, Bernadette A; Totten, Sarah E; Matzinger, Shannon R; Staples, J Erin; Killerby, Marie E; Hughes, Laura J; Matanock, Almea; Beatty, Mark; Tate, Jacqueline E; Kirking, Hannah L; Hsu, Christopher H.
  • Waltenburg MA; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: nvr6@cdc.gov.
  • Whaley MJ; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Chancey RJ; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Donnelly MAP; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA.
  • Chuey MR; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA; County of San Diego Health and Human Services Agency, San Diego, CA.
  • Soto R; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA.
  • Schwartz NG; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA.
  • Chu VT; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA.
  • Sleweon S; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • McCormick DW; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA.
  • Uehara A; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Retchless AC; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Tong S; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Folster JM; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Petway M; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Thornburg NJ; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Drobeniuc J; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Austin B; County of San Diego Health and Human Services Agency, San Diego, CA.
  • Hudziec MM; Colorado Department of Public Health and Environment, Denver, CO.
  • Stringer G; Colorado Department of Public Health and Environment, Denver, CO.
  • Albanese BA; Tri-County Health Department, Greenwood Village, CO.
  • Totten SE; Colorado Department of Public Health and Environment, Denver, CO.
  • Matzinger SR; Colorado Department of Public Health and Environment, Denver, CO.
  • Staples JE; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Killerby ME; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Hughes LJ; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Matanock A; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Beatty M; County of San Diego Health and Human Services Agency, San Diego, CA.
  • Tate JE; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Kirking HL; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
  • Hsu CH; Coronavirus Disease 2019 Response Team, Centers for Disease Control and Prevention, Atlanta, GA.
J Pediatr ; 247: 29-37.e7, 2022 08.
Article in English | MEDLINE | ID: covidwho-1873172
ABSTRACT

OBJECTIVE:

To assess the household secondary infection risk (SIR) of B.1.1.7 (Alpha) and non-Alpha lineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among children. STUDY

DESIGN:

During January to April 2021, we prospectively followed households with a SARS-CoV-2 infection. We collected questionnaires, serial nasopharyngeal swabs for reverse transcription polymerase chain reaction testing and whole genome sequencing, and serial blood samples for serology testing. We calculated SIRs by primary case age (pediatric vs adult), household contact age, and viral lineage. We evaluated risk factors associated with transmission and described symptom profiles among children.

RESULTS:

Among 36 households with pediatric primary cases, 21 (58%) had secondary infections. Among 91 households with adult primary cases, 51 (56%) had secondary infections. SIRs among pediatric and adult primary cases were 45% and 54%, respectively (OR, 0.79; 95% CI, 0.41-1.54). SIRs among pediatric primary cases with Alpha and non-Alpha lineage were 55% and 46%, respectively (OR, 1.52; 95% CI, 0.51-4.53). SIRs among pediatric and adult household contacts were 55% and 49%, respectively (OR, 1.01; 95% CI, 0.68-1.50). Among pediatric contacts, no significant differences in the odds of acquiring infection by demographic or household characteristics were observed.

CONCLUSIONS:

Household transmission of SARS-CoV-2 from children and adult primary cases to household members was frequent. The risk of secondary infection was similar among child and adult household contacts. Among children, household transmission of SARS-CoV-2 and the risk of secondary infection was not influenced by lineage. Continued mitigation strategies (eg, masking, physical distancing, vaccination) are needed to protect at-risk groups regardless of virus lineage circulating in communities.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Adult / Child / Humans Country/Region as subject: North America Language: English Journal: J Pediatr Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Adult / Child / Humans Country/Region as subject: North America Language: English Journal: J Pediatr Year: 2022 Document Type: Article